Hydroxychloroquine is available as the brand-name drug Plaquenil. Generic drugs usually cost less than the brand-name version. Hydroxychloroquine may be used as part of a combination therapy. Other options for hydroxychloroquine plaquenil Plaquenil ivf Compare Hydroxychloroquine vs. Methotrexate, which is better for uses like RA, Lupus and Arthritis. Compare head-to-head ratings, side effects, warnings, dosages, interactions and patient reviews. Trexall methotrexate, Barr Laboratories was first developed as a form of chemotherapy and continues to be used as such; however, this drug has gained popularity as an effective DMARD agent. 23 It has been shown to cause certain ocular side effects even at low doses a typical dose may be 2.5mg orally two to three times per week, the most. Hello hope everyone is well just a quick question, i have been on methotrexate for 2 months increasing from 7.5 to 15 and now to 25mg.weekly now been given plaquenil 400mg daily, has anyone else been on this mixture and has it worked or how long should i wait to see if it works. Hydroxychloroquine is used to treat lupus erythematosus and rheumatoid arthritis. It isn’t fully understood how this drug works to treat lupus erythematosus or rheumatoid arthritis. That means you may need to take it with other drugs. It treats malaria by killing the parasites that cause the disease. Methotrexate trexall and hydroxychloroquine plaquenil Methotrexate vs Plaquenil Comparison -, Managing the Medicine Cabinet Plaquenil pap frequencyChloroquine adverse effectsCyclosporine and plaquenil The chance of damage to the eyes with plaquenil is extremely slim. Your chances of problems with the methotrexate are a bit larger. Many people do end up with both or a combination of othr drugs. PM Which would you pick and why? - Plaquenil or Methotrexate. Methotrexate and plaquenil -. Does anyone take methotrexate and hydroxychloroquine.. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications results of a two-year, randomized, double-blind, placebo-controlled trial. Methotrexate Rheumatrex®, Trexall® Hydroxychloroquine Plaquenil ® Sulfasalazine Azulfidine® Leflunomide Arava® Tumor Necrosis Factor Inhibitors— etanercept Enbrel®, adalimumab Humira ®, and infliximab Remicade® T-cell Costimulatory Blocking Agents—abatacept Orencia® B cell Depleting Agents—rituximab Rituxan® Cyclosporine was stopped and hydroxychloroquine 400 mg/day introduced. After a few weeks the SCLE lesions improved and so did arthralgia and psoriatic lesions, which became less inflamed and reduced in size. One month later, hydroxychloroquine was reduced to 200 mg/day, methotrexate was stopped and prednisone reduced to 5 mg/day.